Keep in touch

MPP 2014 Annual report released

The Medicines Patent Pool Releases 2014 Annual Report: Highlights Progress in Increasing Access to HIV Medicines

MPP signed 20 licensing agreements last year and is now working with 10 generic manufacturers on more than 50 medicine development projects (GENEVA, 20 May 2015) — The Medicines Patent Pool (MPP) released its 2014 Annual Report today highlighting significant steps to increase access to WHO-recommended HIV medicines in low- … Plus d’informations

21 mai 2015

Evénement en marge de la 68ème Assemblée mondiale de la Santé Genève

Interview video avec G. Perry

How to convince big pharma to share  intellectual property to improve global health – une interview video réalisée par Devex (en anglais)

17 mai 2015

Innovation pour la Santé Mondiale Genève

Expression of Interest

Invitation for generic manufacturers to EoI open for DRV/r through the PHTI

The Medicines Patent Pool on Janssen’s Extension of its Access Policy for Paediatric Medicine Darunavir (Statement)

The MPP welcomes Janssen’s announcement today extending its access policy for paediatric formulations of darunavir in support of the Paediatric HIV Treatment Initiative (PHTI). The company’s new policy to waive enforcement of any patent rights for paediatric formulations of darunavir in additional countries, along with its commitment to providing technical … Plus d’informations

The Medicines Patent Pool on Potential Extension of its Mandate to Hepatitis C and Tuberculosis (Statement)

The MPP acknowledges the recent response and input from various civil society organisations and treatment groups on the Foundation’s ongoing assessments to determine the feasibility of extending its mandate to include medicines for hepatitis C (HCV) and tuberculosis (TB). At the request of the UNITAID Executive Board, MPP has been exploring whether, … Plus d’informations

28 avril 2015

4th African Regulatory Conference Dakar, Senegal

Réalisations et impact récents (en anglais)

Le MPP en chiffres et faits